July 14, 2008 - The recently released Government Accountability Office (GAO) report on the growth of imaging services does not provide Congress with suitable recommendations to address medical imaging utilization, said the Medical Imaging & Technology Alliance (MITA) today.

"Tt is disappointing that the GAO report failed to use the most recent data, reference medical guidelines or look at trends in which providers and payers are adopting appropriateness and accreditation criteria to address proper utilization of imaging services," said Andrew Whitman, Vice President of MITA. "As a result, the GAO report obscures how medical imaging utilization decisions are made and the benefit that imaging has to healthcare savings and patient outcomes."

For a more accurate and up-to-date picture of medical imaging Whitman pointed to a recently-released analysis from Avalere Health, www.avalerehealth.net, that demonstrates how the growth of medical imaging services has slowed in recent years. The Avalere Health report examines the most up-to-date Medicare data and also chronicles how medical societies and payers alike are adopting appropriateness guidelines and accreditation criteria to reduce inappropriate scans.

Whitman also said the GAO�s analysis of Radiology Benefit Managers (RBMs) was limited and incomplete, lacking examination of how RBM practices, such as prior authorization requirements and provider limitations, impact savings. He also echoed the Department of Health and Human Services' (HHS) concerns that "[i]t does not appear that the GAO conducted any independent review of the methodology or data used by plans to determine that the use of RBMs was successful or of the manner in which RBMs make their prior authorization determinations."["Appendix V: Comments from the Department of Health and Human Services." Medicare Part B Imaging Services: Rapid Spending Growth and Shift to Physician Offices Indicate Need for CMS to Consider Additional Management Practices. (GAO-08-452). Pg. 48. Government Accountability Office. July 14, 2008.]

Furthermore, the GAO report did not include comment from medical professional associations nor did it analyze what physicians have said regarding their experiences with RBMs generally, and prior authorization specifically.

Rather than assuming that RBMs will resolve concerns about proper utilization, MITA applauds the Members of Congress on both sides of the aisle who instead embraced appropriateness criteria and accreditation in the recently-passed Medicare legislation, as the best approach to ensuring proper utilization, while preserving seniors' access to life-saving diagnostic and therapeutic imaging technologies, said Whitman.

MITA is a division of the National Electrical Manufacturers Association.

Source: MITA

For more information: www.medicalimaging.org and www.nema.org


Related Content

News | X-Ray

April 29, 2026 — Results from a new study* presented at the American Roentgen Ray Society’s (ARRS) 2026 annual meeting ...

Time April 29, 2026
arrow
News | Imaging Software Development

April 28, 2026 — Avatar Medical has been granted FDA 510(k) clearance for Avatar Medical Vision, its software platform ...

Time April 28, 2026
arrow
News | Cardiac Imaging

April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...

Time April 28, 2026
arrow
News | FDA

April 16, 2026 — Royal Philips has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral ...

Time April 20, 2026
arrow
News | Radiology Imaging

April 7, 2026 — Onvida Health and Siemens Healthineers have entered a 10-year Value Partnership¹ designed to bring the ...

Time April 09, 2026
arrow
News | Radiology Business

March 31, 2026 — Radon Medical Imaging, a medical imaging equipment maintenance and repair services company, has has ...

Time March 31, 2026
arrow
News | Radiology Imaging

March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of ...

Time March 30, 2026
arrow
News | Cardiac Imaging

March 28, 2026 — When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it ...

Time March 30, 2026
arrow
News | FDA

March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug ...

Time March 25, 2026
arrow
News | Radiology Imaging

March 23, 2026 — Samsung Medison hsa announced that its U.S. medical imaging businesses, previously operating as ...

Time March 23, 2026
arrow
Subscribe Now